Literature DB >> 20089913

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.

Chris C Tang1, Kathleen L Poston, Vijay Dhawan, David Eidelberg.   

Abstract

Imaging studies show that Parkinson's disease (PD) alters the activity of motor- and cognition-related metabolic brain networks. However, it is not known whether the network changes appear at or before symptom onset. In this study, we examined 15 hemiparkinsonian patients who underwent serial metabolic imaging with [(18)F]-fluorodeoxyglucose (FDG) PET at baseline and again 2.1 +/- 0.6 (mean +/- SD) and 3.9 +/- 0.7 years later. We assessed longitudinal changes in network activity in each cerebral hemisphere, focusing specifically on the "presymptomatic" hemisphere--ipsilateral to the initially involved body side. At the network level, the activity of the PD motor-related pattern (PDRP) increased symmetrically in both hemispheres over time (p < 0.001), with significant bilateral elevations at each of the three time points. Hemispheric expression of the PD cognition-related pattern likewise increased symmetrically (p < 0.001), although significant elevations were not evident on either side until 4 years. At the regional level, putamen metabolism contralateral to the initially affected body side was elevated at all three time points, without longitudinal change. In contrast, in the initially presymptomatic hemisphere, putamen metabolic activity increased steadily over time, reaching abnormal levels only at 4 years. Metabolic activity in the contralateral precuneus fell to subnormal levels by the final time point. These findings suggest that abnormal PDRP activity antecedes the appearance of motor signs by approximately 2 years. The timing and laterality of symptom onset relates to focal asymmetric metabolic changes at the putamenal node of this network.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089913      PMCID: PMC2866050          DOI: 10.1523/JNEUROSCI.4188-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  23 in total

1.  Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism.

Authors:  C Buhmann; F Binkofski; C Klein; C Büchel; T van Eimeren; C Erdmann; K Hedrich; M Kasten; J Hagenah; G Deuschl; P P Pramstaller; H R Siebner
Journal:  Brain       Date:  2005-06-09       Impact factor: 13.501

2.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

3.  Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.

Authors:  Tanya P Lin; Maren Carbon; Chengke Tang; Alon Y Mogilner; Djordje Sterio; Aleksandar Beric; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2008-04-09       Impact factor: 13.501

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

6.  Abnormal regional brain function in Parkinson's disease: truth or fiction?

Authors:  Yilong Ma; Chengke Tang; James R Moeller; David Eidelberg
Journal:  Neuroimage       Date:  2008-10-18       Impact factor: 6.556

7.  Thalamic metabolism and symptom onset in preclinical Huntington's disease.

Authors:  A Feigin; C Tang; Y Ma; P Mattis; D Zgaljardic; M Guttman; J S Paulsen; V Dhawan; D Eidelberg
Journal:  Brain       Date:  2007-09-24       Impact factor: 13.501

8.  Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

Authors:  Y Ma; V Dhawan; M Mentis; T Chaly; P G Spetsieris; D Eidelberg
Journal:  Synapse       Date:  2002-08       Impact factor: 2.562

9.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Authors:  Andrew Feigin; Michael G Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

Review 10.  Abnormal structure-function relationships in hereditary dystonia.

Authors:  M Carbon; D Eidelberg
Journal:  Neuroscience       Date:  2009-01-01       Impact factor: 3.590

View more
  74 in total

Review 1.  Neuroimaging biomarkers for Parkinson disease: facts and fantasy.

Authors:  Joel S Perlmutter; Scott A Norris
Journal:  Ann Neurol       Date:  2014-11-07       Impact factor: 10.422

Review 2.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

Review 4.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 5.  The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.

Authors:  Wei-Xi Xiong; Yi-Min Sun; Rong-Yuan Guan; Su-Shan Luo; Chen Chen; Yu An; Jian Wang; Jian-Jun Wu
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

Review 6.  The utility of metabolomics in natural product and biomarker characterization.

Authors:  Daniel G Cox; Joonseok Oh; Adam Keasling; Kim L Colson; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2014-08-20

Review 7.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

8.  Network Structure and Function in Parkinson's Disease.

Authors:  Ji Hyun Ko; Phoebe G Spetsieris; David Eidelberg
Journal:  Cereb Cortex       Date:  2018-12-01       Impact factor: 5.357

9.  Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia.

Authors:  Vincent A Jourdain; Chris C Tang; Florian Holtbernd; Christian Dresel; Yoon Young Choi; Yilong Ma; Vijay Dhawan; David Eidelberg
Journal:  JCI Insight       Date:  2016-09-22

10.  Validation of nigrostriatal positron emission tomography measures: critical limits.

Authors:  Morvarid Karimi; LinLin Tian; Christopher A Brown; Hubert P Flores; Susan K Loftin; Tom O Videen; Stephen M Moerlein; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.